The ability to rapidly assemble and prototype cellular circuits is vital for biological research and its applications in biotechnology and medicine. Current methods that permit the assembly of DNA circuits in mammalian cells are laborious, slow, expensive and mostly not permissive of rapid prototyping of constructs. Here we present the Mammalian ToolKit (MTK), a Golden Gate-based cloning toolkit for fast, reproducible and versatile assembly of large DNA vectors and their implementation in mammalian models. The MTK consists of a curated library of characterized, modular parts that can be easily mixed and matched to combinatorially assemble one transcriptional unit with different characteristics, or a hierarchy of transcriptional units weaved into complex circuits. MTK renders many cell engineering operations facile, as showcased by our ability to use the toolkit to generate single-integration landing pads, to create and deliver libraries of protein variants and sgRNAs, and to iterate through Cas9-based prototype circuits. As a biological proof of concept, we used the MTK to successfully design and rapidly construct in mammalian cells a challenging multicistronic circuit encoding the Ebola virus (EBOV) replication complex. This construct provides a non-infectious biosafety level 2 (BSL2) cellular assay for exploring the transcription and replication steps of the EBOV viral life cycle in its host. Its construction also demonstrates how the MTK can enable important and time sensitive applications such as the rapid testing of pharmacological inhibitors of emerging BSL4 viruses that pose a major threat to human health.
Introduction
Molecular cloning is the cornerstone of modern biological research. It is required to generate DNA vectors that can encode a myriad of genetic circuits with applications in the fields of cell biology, therapeutics, virology, synthetic biology and biotechnology, among others. These circuits can encompass the expression of endogenous proteins, small RNAs, reporters of gene expression or cellular activity, and other innumerable reagents whose applications extend from basic discovery to medical applications. To move molecular cloning forward into an engineering discipline, with minimal trial and error and reproducible results, the parts that constitute engineered circuits need to be modular, vetted for their function and easy to share. To maximize the range of applications, circuits made from these parts need to be rapidly assembled, amenable to fast prototyping, and not bottlenecked by the delivery method to their target genomic integration sites.
Conventional approaches to produce DNA vectors involve the PCR amplification of DNA fragments from different sources, which are later ligated following digestion with restriction enzymes. This procedure is time consuming, laborious, prone to errors and requires many control steps when subcloning (e.g. sequencing). Due to the shrinking cost of commercial DNA synthesis, ordering gene fragments or entire genes provides a potential avenue to reliably build libraries of DNA vectors. While this technology increases the diversity of parts that can be cloned and removes a DNA source requirement, current pricing, size limitation, and turnaround time remain a significant bottleneck.
In light of these limitations, several strategies have been developed to streamline the assembly of different parts in the construction of DNA vectors for mammalian biology [1] [2] [3] [4] [5] [6] [7] . Notable
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An expansive, modular cloning toolkit for rapid prototyping in mammalian cells
The basis for the MTK is a library of parts that are "domesticated" from source DNA using a Golden Gate (GG) reaction 12 into a standard vector. The resulting plasmid is then sequenced once to ensure fidelity to the source sequence, and then can later be reused as a modular part in a variety of genetic constructs. Similar to previously published work 6 , 3 , 10 , 12 , we utilize the type-IIS restriction enzymes BsaI and BsmbI due to their "reach over" endonuclease activity that leaves arbitrary four base overhangs adjacent to the recognition site. The defining feature for a part vector is a unique four base overhang that categorizes it to similar parts, and ensures the sequential 5' to 3' ligation of parts into a transcriptional unit (TU) of multiple parts.
Due to the hierarchical nature of the MTK, with the library of part vectors sequenced-verified, only diagnostic restriction digests are necessary to verify correct assembly in subsequent GG reactions. We employ BsmBI and BsaI GG reactions in an alternating manner, to assemble a library of part vectors into libraries of TU plasmids, and ultimately into multi-transcriptional unit (multi-TU) plasmids. The 4 day time from source DNA to final plasmid is comparable to alternative cloning methods when including time to sequence verify (Fig. 1a) . However, the significant time reduction comes in the reusability of the confirmed part plasmids where completely redesigned new configurations of final plasmids (e.g. new TUs) can then be assembled from existing parts in only 2 days.
The MTK encompasses part vector categories 1-8 that are sufficient to build and deliver a vast combinatorial library of genetic constructs to cells (Fig. 1b) . Parts 2, 3 and 4 form the core of the TU, specifying the 5' UTR, coding, and 3' UTR sequences, respectively. Part 2 corresponds to promoter sequences that can be specified to drive variable constitutive or inducible expression or recruit diverse host polymerases, such as polymerase III for non-coding RNA transcription. Part 3 vectors are canonical coding sequences that are typically proteins of interest. Part 4 refers to 3' UTR sequences that encode polyadenylation (pA) sequences that terminate transcription, or spacer sequences that couple transcription to the downstream TU.
Finally, parts 1 and 5 correspond to connector sequences that enable the sequential ordering of
TUs into a multi-TU plasmid, with many versions provided in the MTK. For example, if the design objective is to minimize polymerase read-through and maximize independent expression from each TU, then Part 1 implements connectors with insulator sequences 13 . Conversely, if the goal is to enable strongly correlated expression across adjacent TUs, alternative Part 1 vectors consisting of connectors with orthogonal P2A elements are provided. These are cis-acting hydrolase elements that allow the promoter of one TU to drive expression of up to five downstream TUs 14 .
Within these defined parts, further specialization is easily achieved. Lastly, the MTK contains Part 0 destination vectors that allow delivery via viral transduction, transposase transfection and homologous recombination from the same collection of TUs (Fig. 1c) . Unlike other assembly methods, where the genetic constructs must be repeatedly redesigned to accommodate a particular delivery method, within the MTK, one needs only to change the Part 0 vector in the final GG reaction to facilitate different delivery into cells.
Several considerations may determine which destination delivery is appropriate, but this system allows one to recycle TUs and maintain a library of useful units that may be context-specific.
This mammalian cloning toolkit combines intuitive, hierarchical organization, with an expansive library to enable rapid, facile iteration between a variety of genetic constructs that can be integrated into cells without redesign or re-sequencing, irrespective of the delivery method. A comprehensive list of parts can be found in Supp. Table 1 .
MTK enables facile construction of TUs with different levels of expression
In designing genetic constructs, an important consideration is the relative doses of expression strengths between respective genes. Within the MTK, we have seventeen characterized constitutive promoters that span a spectrum of transcriptional expression strengths. We include promoters from a mix of human, mouse and viral origin for a range of expression, alternatives to swap in the event of silencing effects, and a balance of native and transgene promoters for conventional cell lines.
To characterize the relative strengths of these promoters, we assembled a panel of 14
TUs with varied promoter parts driving mAzamiGreen expression, flanked by the bovine growth hormone (Bgh) pA 3' UTR. In an adjacent TU, a CAG promoter expresses mScarlet with the rabbit beta-globin (Rgl) pA 3' UTR (Fig. 2a) . We transiently transfected each multi-TU plasmid into HEK293T cells and normalized the mAzamiGreen expression by mScarlet to control for plasmid copy number. This suite of promoters span a range of 2 orders of magnitude over background, with the strongest promoter, CMV, more than 300-fold greater than a promoter-less mAzamiGreen. The ranked expression strength of the promoters revealed a smooth continuum of expression between 10-fold and 300-fold (Fig. 2a) . Thus this suite of promoters can be used to tailor TU expression levels and leverage overlapping promoter strengths to avoid repeated elements in multi-TU plasmids. The ranked expression of the promoters across human and mouse demonstrates that their relative strengths are largely maintained (Fig. Supplementary   Fig. 1a, b) , suggesting that these promoters are portable across different systems. Additionally, the rank of promoter effect on gene expression is consistent between transient and stably integrated expression, leaving this suite of promoters as a reliable metric for TU design (Fig.   Supplementary Fig. 1c, d ).
Additionally, the MTK allows for further fine-tuning of a TU in a given range using a collection of five different 3' UTR sequences. Similar to the promoter comparison, we generated a circuit with the same constitutive promoter (EF1a) and varied the 3' UTR sequence to compare normalized mAzamiGreen expression (Fig. 2b) . We observed a range of 4-fold change in expression of mAzamiGreen among the three conventional 3' UTR sequences. While the Bgh pA and Rgl pA signals are redundant, the simian virus 40 (SV40) pA signal has a nearly 1.5-fold greater effect on expression than the other pA sequences (Fig. 2c) . This supports the notion that by rationally varying promoter-pA combinations, one can fine-tune incremental changes in expression to complement the log-scale changes accompanied by solely changing promoters.
Moreover, replacing a canonical 3' UTR sequence with either of the spacer sequences diminishes expression of its upstream coding sequence, but the spacers still enable appreciable expression over background. The two spacers differ in their use: including a stop codon allows for efficient reverse-transcription in lentiviral preparation while omitting the stop codon enables read-through in multicistronic plasmids. Finally, the MTK contains two inducible promoters whose use is illustrated in Fig. 6 . This characterized suite of constitutive promoters and 3' UTR's coupled with the facile assembly can generate libraries of fine-tuned expression of a protein of interest. We only explored here a few combinations related to one promoter (EF1a), but other combinations can be easily assembled using the parts already provided in the MTK and assayed by the interested user. 15 , and histone H2B fused to mScarlet separated by P2A sites (Fig. 3a) . Compared to the control version of this construct, which expresses the same proteins in a multi-TU format from repeated, independent promoters, the multicistronic construct conferred a 35% reduction in vector size. Transiently transfected HEK293T cells with the multicistronic vector showed the correct localization of each of the proteins (Fig. 3b) , with no distinguishable difference from the independent multi-TU control. These data demonstrate the feasibility to deploy P2A elements to generate single multicistronic constructs that circumvent the size limitations of conventional viral delivery vectors.
MTK contains linkers encoding
MTK contains landing pad system and accompanying destination vector
When delivering synthetic genetic circuits, it can be essential to have site-specific, single copy integration. In addition, it is important that this integration is efficient and reliable. In order to accomplish this functionality, we included in the MTK a BxBI-dependent landing pad system for integrating synthetic circuits in a locus of choice. The landing pad system is divided into two parts: first, a landing pad cell line; and second, a landing pad transfer vector. As a proof of concept we built a HEK293T cell line with a BxBI landing site in the hAAVS1 locus (hAAVS1 LP), identified by mRuby2 expression and Hygromycin resistance, and tested its ability for site specific recombination.
The landing pad cell line was generated by CRISPR/Cas9-mediated integration of a vector with homology to the hAAVS1 locus. This vector encoded a multicistronic cassette with
Hygromycin resistance and nuclear-localized mRuby2 surrounded by a LoxP site and two FRT sites. The BxBI attP site is located between the promoter and the first gene of this cassette (Fig.   4a ). We chose to integrate the landing pad in the hAAVS1 locus due to its low impact on gene expression 16 . We verified the correct integration of the landing pad cassette by PCR in 8 clones ( Supplementary Fig. 3 ) and continued its characterization in clone #8 due to the monoallelic presence of the landing pad. We further confirmed the presence of the landing pad in the cell line by mRuby2 expression (Fig. 4b) .
The second part of the landing pad system is a transfer vector that encodes the synthetic gene circuit. In order to verify that the transfer vector is correctly integrated at the hAAVS1 landing pad (hAAVS1 LP), we positioned a promoter-less multicistronic cassette encoding Blasticidin resistance and nuclear localized tagBFP downstream of the BxBI attB site. When site specific integration is accomplished, the cell line switches color (from mRuby2 to tagBFP) and resistance (Hygromycin to Blasticidin).
To test the landing pad, we integrated a transcriptional unit that contains H2B fused to mAzamiGreen, driven by the CAG promoter (Fig. 4a) . Upon integration of the transfer vector into the hAAVS1 LP, we noted the decrease in mRuby2 expression together with expression of mAzamiGreen and tagBFP in most cells (Fig. 4b) , with a small fraction of cells showing no or incorrect integration of the transfer vector. Gratifyingly, clone #2, in which both wild type alleles of hAAVS1 locus were replaced by the landing pad construct, showed two populations as measured by fluorescence upon integration of the transfer vector. This suggested that these two populations had one or two copies that integrated into the genome, further demonstrating the efficiency of integrating into the landing pad ( Supplementary Fig. 3b ).
While our results have shown the functionality of the landing pad in one genomic locus, this system is by design generalizable to additional loci of interest or additional species by simply replacing the homology arms in the CRISPR-Cas9 vector. It is also straightforward to replace resistance and fluorescent protein markers in both the landing pad and transfer vectors, as these vectors are generated by GG assemblies of parts already existing in the MTK library. In the first library, we combined one of three localization tags (NLS (nucleus), NES (cytoplasm) and Lyn (plasma membrane)) with four fluorescent proteins (tagBFP, mAzamiGreen, mScarlet and iRFP713) ( Next, we sought to explore whether the MTK facilitates the construction of combinatorial CRISPR knockout libraries. To do that, we generated a library of sgRNAs that target two fluorescent proteins. We first assembled TUs that contain sgRNAs that target tagBFP, mScarlet, or that are non-targeting 17 . We combined those in a multi-TU unit so that a final Lentiviral delivery plasmid contains 2 guide RNAs, ensuring that we had any one of four possible outcomes (tagBFP knockout, mScarlet knockout, tagBFP and mScarlet knockout, or non-targeting control) in the final library ( This is in accordance with the inefficiency of the mScarlet sgRNA targeting (Fig. 5f ).
MTK allows for rapid, one step combinatorial construction of libraries
To test the combinatorial assembly approach, we independently transduced the 3C cell line with 4 biological replicates of the sgRNA library. After 14 days of selection, we measured tagBFP and mScarlet expression and identified cells belonging to the four possible outcomes of the viral library, suggesting that all combinatorial possibilities are achievable through this method ( Fig. 5g) . Importantly, the fraction of each outcome was in accordance with the predictions of the classifier. Taken together, these data argue that the MTK is able to rapidly generate libraries of vectors that express proteins variants or multiple sgRNAs. Additionally, these libraries can be inserted into the genome by transduction or recombination and the diversity of variants, as well as the correct ratio of each variant in the library, is maintained through all cloning steps.
MTK facilitates optimization of combinatorial gene circuits for synthetic biology applications
The ability to prototype gene circuits in synthetic biology is contingent on rapidly assessing part efficacy, optimizing and implementing changes for the next iteration. The vast combinatorics present in the MTK library present a fruitful opportunity to prototype, test, and iterate on circuit designs in parallel. To explore this idea, we constitutively expressed deactivated Streptococcus pyogenes and Streptococcus aureus CRISPR Cas9 (dSpCas9 and dSaCas9, respectively) C-terminally fused to either a fluorescent protein (FP), repressor domain (Krüppel associated box, KRAB), or an activator domain (VP64-p65-Rta, VPR) [19] [20] [21] [22] [23] . These protein-effector combinations were targeted to two canonical inducible promoters: the GAL4
Upstream Activating Sequence (UAS) or the Tet Responsive Element (TRE) (Fig. 6a) . Each gene circuit was assembled adjacent to a constant TU with constitutive EF1a expression of iRFP713, in parallel. In total, twelve different circuits capable of modulating mAzamiGreen expression. We transiently transfected these circuits into HEK293T cells and normalized changes in mAzamiGreen expression by iRFP713.
As expected, in each of the circuit iterations, expression of mAzamiGreen relative to the iRFP713 control is below basal with the repressor domain, or above basal with the activator domain (Fig. 6b) . However, the degree of activation and repression varies considerably across each circuit. More specifically, dSpCas9 achieves approximately 3-fold reduction in fluorescence through the KRAB effector and 30-fold induction in both the UAS and TRE promoters. In contrast, the dSaCas9 fused to VPR is an effective activator increasing expression 30-fold, but when fused to a KRAB domain, dSaCas9-mediated repression is comparable to background FP expression levels. The data also suggests that the TRE promoter exhibits higher basal activity due to its overall greater repression, and lower activation when compared to the UAS promoter. This information, in light of other considerations such as protein size or protospacer adjacent motif (PAM) sequence versatility, expedites the rational design and optimization of Cas9-controlled gene expression circuits through the parallelization of prototyping. As a result, this strategy can serve as a useful reference for further customized circuits, and a demonstration that this prototyping can be scaled to easily screen various combinations of genetic circuits.
MTK streamlines the generation of endogenous viral circuits
Viruses represent a class of naturally occurring genetic circuits that are particularly amenable to construction using the MTK due to their modular genome organization. In particular, the MTK can be relevant to speed the investigation of emerging viral agents by rapidly "booting up" their genes in a mammalian host. A key example corresponds to the filoviruses, a family of highly pathogenic genetically related viruses that includes the Ebola and 7a ).
In the late 1990's a 6-plasmid BSL2 ribonucleoprotein (RNP) minigenome replicon system was developed for EBOV to accelerate research on the transcription and genome replication sub-lifecycle of the virus, and aid antiviral discovery efforts 25, 26 . This system requires expression of four viral proteins (NP, VP35, VP30, and Lpol), along with aT7 polymerase, and a T7-driven minigenome reporter construct 25 ( Fig. 7a) . Transfection of these 6 plasmids into mammalian cells results in expression of NP, VP35, VP30, Lpol viral proteins, and the T7 polymerase. The viral proteins recognize and associate with the T7-transcribed minigenome reporter RNA template (vRNA (-)) then catalyze transcription (mRNA) and replication (aRNA (+)), resulting in measurable reporter gene expression (Fig. 7a ). While the 6-plasmid system has been a valuable tool for initial discoveries into EBOV replication and transcription, it is not readily amenable to systematic studies due to its transient nature, inefficiency (all 6 plasmids must be present in the same cell), and variability that limits scaling. More recently, a stable cell line version of this system has been developed via sequential integration of RNP viral proteins 27 .
While these cells displayed a highly stable minigenome RNA-protein complex and more robust minigenome activity than the previously reported 6-plasmid systems, generation of this cell line entailed a time-intensive, multi-step approach that is not amenable for every emerging virus or variants of the same virus.
Given the urgent need that outbreaks of emerging viral agents pose to human health, we sought to test if the MTK could be harnessed to streamline and accelerate the generation of BSL2 reagents like the stable EBOV RNP cell lines. We synthesized the EBOV RNP genes and used the MTK multicistronic workflow with Left connector parts that encode P2A ribosomal skipping site elements to rapidly assemble a 4-cistronic construct of Zaire ebolavirus (ZEBOV-4cis) ( Fig. 5a ). These vectors provide distinct types and numbers of genome integration events ( via transposase (PiggyBac) or integrases (PhiC31, BxBI)) . Digestion followed by gel electrophoresis confirmed high cloning efficiency and correct assembly of ZEBOV-4cis in all 5 destination vectors ( Supplementary Fig. 5a ). In transient transfections, all ZEBOV-4cis constructs showed no impact on cell viability and displayed levels of minigenome activity similar to the 6-plasmid system and ~40-60-fold higher activity than the cells lacking Lpol (Fig. 7b, Supplementary Fig. 5b ).
We next employed the PiggyBac transposon system to achieve high copy integration of the ZEBOV-4cis construct for a robust functional minigenome reporter readout. HEK293T cells were co-transfected with PiggyBac transposon and the PiggyBac donor construct (MTK043-ZEBOV-4cis) that contains a hygromycin marker cassette, followed by selection with hygromycin for 7 days (Fig. 7c ). This resulted in 2 independent stable populations of HEK293T cells expressing ZEBOV RNP proteins, as determined by eGFP minigenome reporter signal ( Supplementary Fig. 5c ). Clonal cell lines were isolated and expanded from these 2 stable populations in an additional 1-2 weeks. This workflow simplified and speeded the generation of stable EBOV RNP cell lines compared to the previously reported system 27 .
We characterized the resulting EBOV RNP stable cell lines via quantitative minigenome reporter assays, protein expression and localization studies, and analysis of susceptibility to previously described small molecule inhibitors of ZEBOV RNP minigenome activity. ZEBOV-4cis stable populations and clonal cells yielded comparable nLuc minigenome reporter activity (Fig.   7d ). ZEBOV viral proteins in both the stable and clonal cell populations were readily detectable with NP and VP35 specific antibodies, and showed expression levels similar to transiently transfected ZEBOV-4cis (Fig. 7e) . Additionally, based on the presence of 2A peptide tag that remains at the C-terminus of each of these proteins following "self-cleavage" due to ribosome skipping, NP, VP35, and VP30 were each detectable with an antibody raised against the 2A peptide (Fig. 7e) . Larger multi-ORF fusion protein products were not readily detected with the 2A peptide antibodies, indicating efficient cleavage occurred at each of the P2A sites encoded within the ZEBOV-4cis construct. This demonstrates the added benefit that the P2A parts in the MTK provide a potential "universal" method to detect protein expression from multicistronic constructs. This is especially useful for analysis of novel emerging viruses or other proteins where specific antibodies are not available.
Immunofluorescence analysis with VP35 and 2A antibodies show characteristic cytoplasmic punctate structures (Fig. 7f) representing inclusion bodies that are sites of virus replication [28] [29] [30] , indicating correct localization of the P2A-tagged viral proteins in these stable cell lines. Due to the lack of available specific antibodies for the Lpol and the lack of a P2A tag in the construct, the Lpol expression cannot be assayed by Western blot or immunofluorescence analysis. However, the fact that these cells support minigenome activity (Fig. 7b and 7d) confirms that Lpol is expressed.
To further characterize the ZEBOV-4cis stable RNP cell line system, we also tested their susceptibility to previously identified EBOV small molecule inhibitors: Gedunin, an inhibitor of heat shock protein 90, and 6-Azauridine, a nucleoside analog 31, 32 . ZEBOV-4cis stable cells were transfected with the ZEBOV nLuc minigenome reporter and treated with DMSO (1%, control), Gedunin (5 µM), or 6-Azauridine (5 µM) for 2 days. Luciferase assays revealed that both compounds inhibited minigenome activity by >50%, with minimal impact on cell viability (Fig.   7g ). These data indicate that the ZEBOV-4cis stable cell lines generated here are similarly susceptible to known inhibitors identified in transient RNP minigenome systems or recombinant virus systems 31, 32 . Therefore, our approach implemented through the MTK introduces a robust workflow for generating BSL2 systems for filoviruses and other viral agents as they emerge, providing a critical opportunity to implement rapid chemical compound susceptibility screens using these reagents.
Discussion
A key element of cellular engineering for basic science or therapeutic purposes is the ability to quickly build, test, and iterate on designs. This is currently infeasible in mammalian cells using conventional methods in molecular cloning. In this work, we presented the MTK, a platform that takes an important step to remove bottlenecks in mammalian cellular engineering.
A major asset of the MTK is a large, characterized suite of modular parts to build versatile TUs. Despite the modularity in the MTK, there are situations where caution is needed in using certain parts. For example, on occasion, internal BsaI and BsmBI sites must be removed from coding sequences with a synonymous mutation. For non-coding sequences, it is often difficult to foresee the impact of base switching during domestication of the corresponding part. It is possible to domesticate these parts and retain internal BsaI or BsmBI cut sites with a minor modification of the GG protocol (See "end-on" GG Protocol, Methods). In addition, while the MTK allows flexibility in the assembly of a wide variety of TUs, the sequence of TUs in a final multi-TU plasmid is prescribed at the TU assembly step (e.g. a TU assembled with an LS part 1 will always be the most upstream TU). Therefore, it is prudent to follow general design principles in order to maximize their repurposing 33 Finally, while not explored in this work, the MTK constitutes a launching platform for additional exciting capabilities. For example, the MTK already expedites the production of sgRNA expression vectors, and with the prevalence of sgRNA screening approaches, we envision incorporating barcoding capabilities that can be read by bulk and single-cell sequencing technologies [36] [37] [38] . Furthermore, within the current MTK framework all TUs are read in the same direction. However, it is conceivable to design connector parts (1 and 5) that reverse the orientation of a TU to enable more autonomy in genetic circuit design and optimize transcriptional efficiency 33 . Lastly, the emergence of robotics and high-throughput liquid handling promises an exciting future avenue leveraging automation to streamline assembly. Overall, the MTK represents a significant advancement in cloning infrastructure to further expedite the growth, applications and scope of biological research and biotechnology. Thermocycler protocols: The "GG Long" protocol is primarily used for assembly reactions. The reaction temperature is initially held at 45°C for 2 min to digest the plasmids followed by 20°C for 4 min to anneal constituent parts together. After repeating these first two steps 24 times, the temperature is increased to 60°C for 10 min to digest remaining recognition sites and inactivate the ligase. Then the temperature is held at 80°C for 10 min to inactivate the enzyme. Lastly, the reaction is held at 12°C indefinitely. The "GG End-On" protocol is used when BsaI or BsmBI sites need to be retained in the final product. The temperature is initially held at 45°C for 2 min to digest the plasmid followed by 20°C for 5 min to anneal and ligate the resulting plasmid.
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These steps are cycled 24 times and then held at 16°C indefinitely.
Domestication of Parts .
Forward and reverse primers ordered from IDT (www.idtdna.com) were manually designed to anneal to source DNA. Internal BsaI and BsmBI sites were removed and tandem BsaI and BsmBI sites were appended to both the 5' and 3' ends of the sequence. PCR was performed with the general reaction mixture of 10 μL Q5 polymerase master mix (NEB MO492S) using 1 μL each of the forward and reverse primers (10 μM) and 0.5 μL of source DNA. The desired PCR product was gel extracted (ThermoFisher) and 1 μL of the final elution added to a BsmBI-mediated GG reaction (described above) with the YTK001 domestication vector. The resulting product was transformed into bacteria and grown in selective LB overnight.
Plasmid DNA was extracted (ThermoFisher MiniPrep kit) and sequenced verified.
Oligo Annealing . Oligos were designed such that at least 15 bases were complementary and had desired sequence and sticky ends. To anneal oligos into double stranded DNA, we prepared a reaction mixture as follows: 1 μL of each oligo (100 μM), 1 μL T4 Ligase Buffer (NEB), 1 μL T4 PNK, 6 μL water. Mixture was incubated at 37°C for 1 hr and then diluted to a volume of 200 μL. To anneal the oligos, a thermocycler protocol was prepared to hold the temperature of the reaction at 96°C for 6 min, and ramp down 0.1°C per second to 23°C. The reaction is then held at 23°C indefinitely.
Geneblocks. Gene fragments were ordered from IDT as either whole constructs or partial constructs with complementary overhangs to ensure proper domestication.
TU assembly . Part 1-5 plasmids were pooled together with a recipient Part 678 plasmid following a 2:1 molar ratio in a BsaI-mediated GG reaction as described above.
MTU Assembly . Constituent transcriptional unit plasmids were pooled in a 2:1 molar ratio with the destination vector in a BsmBI-mediated GG reaction as described above.
Mammalian Cell Culture and Transfection
HEK293T and 3T3 cells were maintained in DMEM (Dulbecco's Modified Eagle Medium, Gibco)
supplemented with 10% Fetal Calf Serum (SAFC) and passaged every ~3 days.
Transfections for transient and recombinase-based expression were done in quadruplicate, with Lipofectamine 2000 (Invitrogen), according to manufacturer's instructions. Transfections for
Zaire ebolavirus RNP assays were performed in duplicate or triplicate using standard calcium phosphate transfection methods.
Lentiviral Production
For lentiviral generation, 24h before transfection, 5E5 HEK293T cells were plated in a 6 well plate containing 2mL of growth media. Equimolar amounts of transfer vector and packaging vectors (pCMV-dR8.91 and pCMV-VSV-G), with a total amount of 4µg DNA, were transfected using Lipofectamine 2000 (Invitrogen), according to manufacturer's instructions. Media was changed after 16h and virus were collected 48h after transduction, by filtering supernatant through a 0.45µm filter (Millipore SLHV033RS).
For transductions, 1E5 target cells were infected with 1mL, 100µL or 10µL of viral supernatant supplemented with 4ug/mL of polybrene (SCBT sc-134220)
Flow Cytometry and Data Analysis
For the analysis of promoter, 3'UTR expression and hAAVS1 LP expression, cells were collected in 96 well plates (Corning) and measured using an LSR2 flow cytometer (BD).
mAzamiGreen (excitation at 488 nm, emission at 530 nm), mRuby2 or mScarlet (excitation at 561 nm, emission between 610 and 620 nm) and tagBFP (excitation at 355 nm, emission at 450 nm) fluorescence levels were recorded for 10000 events. Gating of single cells, normalization of fluorescence levels, and statistical analysis was performed with custom python scripts.
Microscopy and Image Processing
For 
Compounds:
Gedunin (CAS 2753-30-2) (Fisher Scientific # 33871) and 6-Azauridine (Sigma # A1882-1G)
were resuspended in DMSO to generate a 1mM stock solution. Stock solutions were serially diluted in DMSO and media to treat cells with a final concentration of 5µM in 1% DMSO.
Western blot and Immunofluorescence analyses:
Cell lysates were prepared in RIPA lysis and extraction buffer (Thermo #89900) containing protease inhibitors (Sigma #P8340) for Western blotting. Lysates were resolved by SDS-polyacrylamide gel electrophoresis (PAGE), transferred to a polyvinylidene difluoride (PVDF) membrane, and subjected to Western blotting using primary antibodies: rabbit 
Minigenome reporter assays (luciferase, GFP)
ZEBOV minigenome reporter construct (p2.0-3E5E-nLuc, 250 ng) and T7-expression plasmid of T7-expression plasmid were co-transfected. Nano luciferase levels were assayed as above and eGFP signal was captured via microscopy (Leica, 4X magnification). Figure 7 
